Latest news
RxSight: Guidance Withdrawal and Strategy Reset Prompt Travis Steed to Maintain Sell Rating Amid Near-Term Execution Risks - TipRanksTipRanks · Thu, 06 Aug 2026 22:53:41 GMTSolventum (SOLV) Q4 2025 Earnings Call Transcript - FortuneFortune · Thu, 06 Aug 2026 15:17:36 GMTThe 5 Most Interesting Analyst Questions From Stryker’s Q2 Earnings Call - StockStoryStockStory · Thu, 06 Aug 2026 09:02:01 GMTSolventum (SOLV) Q2 2026 Earnings Call Transcript - FortuneFortune · Thu, 06 Aug 2026 03:30:00 GMT5 Insightful Analyst Questions From GE HealthCare’s Q2 Earnings Call - StockStoryStockStory · Wed, 05 Aug 2026 09:28:56 GMTAnalysts Offer Insights on Healthcare Companies: Stryker (SYK), Alignment Healthcare (ALHC) and McKesson (MCK) - The Globe and MailThe Globe and Mail · Sat, 01 Aug 2026 17:38:00 GMTTravis Steed Maintains Hold on Baxter, Lifts Price Target to $28 Amid Improved Growth but Gradual Earnings Outlook - TipRanksTipRanks · Fri, 31 Jul 2026 11:54:09 GMT